What Is CJC-1295 With DAC?
CJC-1295 with DAC is a synthetic long-acting analog of growth hormone-releasing hormone, or GHRH.
The term DAC refers to a Drug Affinity Complex modification designed to increase association with circulating albumin and substantially extend the peptide’s biological persistence.
SUNONE supplies CJC-1295 with DAC, CAS 446262-90-4, as an HPLC-characterized lyophilized research peptide for qualified laboratory, analytical and biopharmaceutical applications.
SUNONE CJC-1295 With DAC:
Why Does the DAC Modification Matter?
The most important feature of CJC-1295 is not simply that it is a GHRH analog.
It is the DAC modification.
Research on long-acting CJC-1295 showed that the compound can associate with endogenous albumin, extending its persistence from the short duration typical of native GHRH into a multi-day pharmacological profile.
This makes CJC-1295 with DAC useful for research involving:
- GHRH receptor signaling;
- GH/IGF-1 axis biology;
- peptide–protein interactions;
- albumin-binding peptide design;
- long-acting peptide pharmacology;
- peptide stability;
- endocrine signaling research.
CJC-1295 With DAC vs. No DAC: They Should Not Be Treated as the Same Material
One of the biggest sources of confusion in Google search results is the phrase “CJC-1295 no DAC.”
CJC-1295 with DAC and products marketed as CJC-1295 without DAC should not automatically be treated as interchangeable compounds.
The published human pharmacology studies most commonly cited for CJC-1295 investigated the long-acting CJC-1295 formulation associated with DAC technology.
By contrast, products marketed as CJC-1295 no DAC or Modified GRF 1-29 have a different pharmacological profile, and comparable controlled human evidence is much more limited.
For research procurement, the words “CJC-1295” alone are therefore not enough.
Researchers should confirm exactly which molecular form is being supplied.
What Does Human CJC-1295 Research Show?
Early controlled human studies investigated long-acting CJC-1295 in healthy adults.
Researchers reported sustained increases in circulating growth hormone and IGF-1, with effects lasting substantially longer than native GHRH.
A separate study examining GH secretion patterns found that CJC-1295 increased basal and mean GH levels while GH pulsatility was preserved.
This is scientifically important because some online discussions claim that long-acting CJC-1295 completely eliminates normal GH pulses.
The available human research does not support such a simple interpretation.
However, these studies were small and short-term. They do not establish broad claims involving muscle growth, fat loss, recovery, anti-aging or long-term safety.
What Do CJC-1295 With DAC Reviews Say?
Online CJC-1295 with DAC reviews are highly mixed.
Positive anecdotal discussions sometimes mention:
- perceived improvements in recovery;
- changes in body composition;
- increased sense of wellbeing;
- preference for the longer-acting formulation.
Negative discussions frequently mention:
- water retention;
- fatigue;
- flushing;
- headaches or dizziness;
- concerns about prolonged GH/IGF-1 elevation;
- little or no noticeable effect.
Many online users also combine CJC-1295 with other peptides or compounds, making it impossible to attribute their experience to CJC-1295 alone.
These reviews should therefore be treated as anecdotal search sentiment rather than controlled scientific evidence.
Why CJC-1295 Purity Alone Is Not Enough
A headline such as “99% CJC-1295” does not fully answer the most important analytical question:
Which CJC-1295 is actually present?
For professional research, laboratories should consider:
Molecular Identity
Analytical testing should support the expected CJC-1295 with DAC structure.
HPLC Purity
Batch-specific HPLC data can help characterize peptide purity and related impurities.
Mass Spectrometry
MS identity testing is particularly useful for distinguishing the expected molecular material from incorrectly labeled or structurally different peptides.
DAC Status
The supplier should clearly identify whether the material is the long-acting DAC form.
Batch-Specific COA
A Certificate of Analysis should correspond to the actual manufacturing lot rather than a generic reference document.
SUNONE supplies CJC-1295 with DAC, CAS 446262-90-4, with analytical documentation available according to batch specification.
CJC-1295 Research: Identity Before Marketing Claims
CJC-1295 is often marketed online using broad phrases such as “growth hormone peptide,” “recovery peptide” or “body-composition peptide.”
For laboratory research, these descriptions are less useful than knowing the exact molecular identity.
The meaningful scientific questions are:
Does the material contain the DAC modification? Is its molecular mass consistent with the intended compound? Does HPLC support purity? Can the supplier provide batch-specific analytical documentation?
For CJC-1295 research, correctly identifying the molecule is the first step toward interpreting any experimental result.
SUNONE CJC-1295 research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame.
Leave a Reply